Achieving Hepatitis C Elimination in Pakistan

Modelling suggests that achieving the World Health Organization incidence target for hepatitis C virus (HCV) elimination in Pakistan could cost US$3.87 billion over 2018 to 2030. However, the economic benefits from integrating services or improving productivity were not included. A modelling study and economic analysis published in PLOS Medicine concluded that investment in HCV elimination can bring about substantial societal health and economic benefits for Pakistan.

The full publication Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis can be accessed here.